Concepedia

Annemijn P. A. Wierenga

AP

14

Publications

363

Citations

12

H-Index

2016

Active since

Affiliations

Leiden University Medical Center(Current)

Erasmus MC

Erasmus University Rotterdam

Université Paris Sciences et Lettres

Institut Curie

Annemijn P. A. Wierenga is an author at Leiden University Medical Center specializing in cancer research, immunology, and tumor microenvironment.

ORCID

Top concepts

Publications per year

2016–2023

14

Publications

14

Loss of BAP1 Is Associated with Upregulation of the NFkB Pathway and Increased HLA Class I Expression in Uveal Melanoma

Zahra Souri, Annemijn P. A. Wierenga, Christiaan van Weeghel et al. · Cancers · 2019 · 48 citations · Full text

, , +29

Aqueous Humor Biomarkers Identify Three Prognostic Groups in Uveal Melanoma

Annemijn P. A. Wierenga, Jinfeng Cao, Henk Mouthaan et al. · Investigative Ophthalmology & Visual Science · 2019 · 43 citations · Full text

LAG3 and Its Ligands Show Increased Expression in High-Risk Uveal Melanoma

Zahra Souri, Annemijn P. A. Wierenga, Wilma G. M. Kroes et al. · Cancers · 2021 · 42 citations · Full text

Tumour Angiogenesis in Uveal Melanoma Is Related to Genetic Evolution

Niels J. Brouwer, Gülçin Gezgin, Annemijn P. A. Wierenga et al. · Cancers · 2019 · 32 citations · Full text

HDAC Inhibition Increases HLA Class I Expression in Uveal Melanoma

Zahra Souri, Aart G. Jochemsen, Mieke Versluis et al. · Cancers · 2020 · 32 citations · Full text

, , +17

Rows per page

1–5 of 14